The heat shock response (HSR) is a conserved cellular mechanism critical for adaptation to environmental and physiological stressors, with broad implications for cell survival, immune responses, and cancer biology. While the HSR has been extensively studied at the proteomic and transcriptomic levels, the role of lipid metabolism and membrane reorganization remains underexplored. Here, we integrate mass spectrometry-based lipidomics with RNA sequencing to characterize global lipidomic and transcriptomic changes in HeLa cells exposed to three conditions: control, heat shock (HS), and HS with eight hours of recovery. Heat shock-induced extensive lipid remodeling, including significant increases in fatty acids, glycerophospholipids, and sphingolipids, with partial normalization during recovery. Transcriptomic analysis identified over 2700 upregulated and 2300 downregulated genes under heat shock, with GO enrichment suggesting potential transcriptional contributions to lipid metabolism. However, transcriptional changes alone did not fully explain the observed lipidomic shifts, suggesting additional layers of regulation. Joint pathway analysis revealed enrichment in glycerophospholipid and sphingolipid metabolism, while network analysis identified lipid transport regulators (STAB2, APOB), stress-linked metabolic nodes (KNG1), and persistent sphingolipid enrichment during recovery. These findings provide a comprehensive framework for understanding lipid-mediated mechanisms of the HSR and highlight the importance of multi-omics integration in stress adaptation and disease biology.

Heat shock protein A1A (HSPA1A), a major heat shock (HS) protein, is known to translocate to the plasma membrane (PM) in response to cellular stress and cancer, where it plays protective roles in membrane integrity and stress resistance. Although phosphatidylinositol 4-phosphate [PI(4)P] is essential in this translocation, the signals that trigger and facilitate HSPA1A's movement remain undefined. Given that membrane lipid composition dynamically shifts during stress, we hypothesized that HS-induced PI(4)P changes are crucial for HSPA1A's PM localization. To test this hypothesis, we investigated the mechanisms driving PI(4)P changes and HSPA1A PM localization under HS. Lipidomic analysis, enzyme-linked immunosorbent assay (ELISA), and confocal imaging revealed a rapid PI(4)P increase at the PM post-HS, with levels peaking immediately after HS (0 h recovery) and declining by 8 h of recovery. RNA sequencing and protein quantification indicated no transcriptional increase in PI4KIII alpha, the kinase responsible for PI(4)P synthesis, suggesting an alternative regulatory mechanism. Hypothesizing that HS enhances PI4KIII alpha activity, we performed ELISA coupled with immunoprecipitation, confirming a significant rise in PI4KIII alpha activity following HS. Functional analyses further demonstrated that RNAi-mediated PI4KIII alpha depletion or pharmacological PI(4)P reduction, using GSK-A1, impairs HSPA1A's localization to the PM, confirming that HSPA1A translocation is PI(4)P-dependent. Our findings identify PI4KIII alpha activity as a key regulator of PI(4)P accumulation and subsequent HSPA1A recruitment to the PM in stressed and cancer cells. This lipid-mediated response offers new insights into stress adaptation and potentially modifiable pathways for therapeutic interventions to control HSPA1A function in cancer.

Electrospray ionization (ESI) is a foundational technique in mass spectrometry (MS) widely applied to measure nonvolatile molecules in diverse chemical and biological samples. Yet variation in ESI-MS instrumentation, operating settings, and parameters such as solvent composition creates specific, local ionization environments that drive the formation of select ion species for individual analytes. As ESI continues to advance analytical discovery, understanding the extent to which variation in ion species formation impacts intra- and inter-experimental results is essential. Here, we assessed ion species formation by analyzing an internal retention time standard (IRTS) mixture across ten laboratories employing high-resolution ESI-MS instrumentation from four vendors (Agilent Technologies, ThermoFisher Scientific, Shimadzu Corporation, and Waters Corporation). Instrument vendors were considered not as a benchmark of performance, but as a practical framework to capture differences in source design, ion optics, and analyzer/detectors that are inherently coupled to commercial platforms. Despite the use of standardized extraction and chromatographic protocols, differences in instrument configuration, source conditions, and method execution resulted in variation in ion species formation across vendors, among laboratories using instruments from the same vendor, and even within individual laboratories. These findings demonstrate that, even with standardized methods, the collective influence of local ionization environments on ion species formation remains a critical obstacle for interpreting LC–MS small molecule data and improving reproducibility and comparability across studies.